Cellectar Biosciences - 14 Year Stock Price History | CLRB

Historical daily share price chart and data for Cellectar Biosciences since 2005 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Cellectar Biosciences as of March 22, 2019 is 2.31.
Cellectar Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.0093 1.5800 2.8500 1.5800 2.3100 49.03%
2018 7.0838 13.7000 13.7000 1.2900 1.5500 -88.69%
2017 17.2692 12.8000 26.6000 11.2000 13.7000 12.30%
2016 31.0365 73.2000 76.1500 10.5000 12.2000 -83.40%
2015 250.6595 306.0100 355.0000 68.5000 73.5000 -76.21%
2014 552.5469 760.0000 840.0000 198.9500 309.0000 -58.24%
2013 910.9524 1480.0000 1580.0000 600.0000 740.0000 -50.00%
2012 1921.5200 900.0000 4000.0000 860.0000 1480.0000 68.18%
2011 4315.7937 12240.0000 15300.0000 740.0000 880.0000 -90.41%
2010 113632.8571 908820.0000 908820.0000 6120.0000 9180.0000 -98.82%
2009 215997.1429 143820.0000 777240.0000 104040.0000 777240.0000 440.43%
2008 158587.8261 186660.0000 244800.0000 67320.0000 143820.0000 -21.67%
2007 260855.8566 275400.0000 416160.0000 131580.0000 183600.0000 -31.82%
2006 374575.6972 581400.0000 691560.0000 192780.0000 269280.0000 -56.44%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.011B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.32
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
HEXO (HEXO) $1.340B 0.00
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
InfuSystems Holdings (INFU) United States $0.091B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29